{"id":90516,"date":"2026-05-18T16:29:09","date_gmt":"2026-05-18T10:59:09","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=90516"},"modified":"2026-05-18T16:29:11","modified_gmt":"2026-05-18T10:59:11","slug":"max-healthcare-institute-analyst-review-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/max-healthcare-institute-analyst-review-2026\/","title":{"rendered":"Max Healthcare Institute Analyst Review May 2026"},"content":{"rendered":"<p>This <strong><a href=\"https:\/\/univest.in\/user\/stocks\/maxhealth\/max-healthcare-institute-ltd-share-price-today\">Max Healthcare Institute<\/a> analyst review<\/strong> for May 2026 covers the key data investors need for MAXHEALTH at its current price of Rs 1,037.20. Max Healthcare Institute (NSE: MAXHEALTH) is one of India&#8217;s largest hospital chains with a market capitalisation of approximately Rs 1,00,000 crore, operating over 4,000 beds across 19 hospitals. The analyst consensus target of Rs 1,250 implies meaningful upside, and this <strong>Max Healthcare Institute analyst review<\/strong> examines technical levels, business performance, valuation, and key risks that will determine whether MAXHEALTH achieves that target through FY27.<\/p>\n<p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/max-healthcare-institute-analyst-review-2026\/#Max_Healthcare_Institute_Company_Snapshot_May_2026\" title=\"Max Healthcare Institute Company Snapshot May 2026\">Max Healthcare Institute Company Snapshot May 2026<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/max-healthcare-institute-analyst-review-2026\/#Analyst_Insight_in_This_Max_Healthcare_Institute_Analyst_Review\" title=\"Analyst Insight in This Max Healthcare Institute Analyst Review\">Analyst Insight in This Max Healthcare Institute Analyst Review<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/max-healthcare-institute-analyst-review-2026\/#Technical_Analysis_in_This_Max_Healthcare_Institute_Analyst_Review\" title=\"Technical Analysis in This Max Healthcare Institute Analyst Review\">Technical Analysis in This Max Healthcare Institute Analyst Review<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/max-healthcare-institute-analyst-review-2026\/#Key_Support_and_Resistance_Levels\" title=\"Key Support and Resistance Levels\">Key Support and Resistance Levels<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/max-healthcare-institute-analyst-review-2026\/#Business_Segment_Analysis\" title=\"Business Segment Analysis\">Business Segment Analysis<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/max-healthcare-institute-analyst-review-2026\/#Tertiary_and_Quaternary_Care_Hospitals_Delhi_NCR\" title=\"Tertiary and Quaternary Care Hospitals (Delhi NCR)\">Tertiary and Quaternary Care Hospitals (Delhi NCR)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/max-healthcare-institute-analyst-review-2026\/#Oncology_and_Transplant_Centres_of_Excellence\" title=\"Oncology and Transplant Centres of Excellence\">Oncology and Transplant Centres of Excellence<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/max-healthcare-institute-analyst-review-2026\/#MaxHome_and_Diagnostics_Expanding_Revenue_Streams\" title=\"Max@Home and Diagnostics (Expanding Revenue Streams)\">Max@Home and Diagnostics (Expanding Revenue Streams)<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/max-healthcare-institute-analyst-review-2026\/#Valuation_in_This_Max_Healthcare_Institute_Analyst_Review\" title=\"Valuation in This Max Healthcare Institute Analyst Review\">Valuation in This Max Healthcare Institute Analyst Review<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/max-healthcare-institute-analyst-review-2026\/#Trade_Outlook_for_Max_Healthcare_Institute\" title=\"Trade Outlook for Max Healthcare Institute\">Trade Outlook for Max Healthcare Institute<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/max-healthcare-institute-analyst-review-2026\/#Key_Risks_for_Max_Healthcare_Institute_in_FY27\" title=\"Key Risks for Max Healthcare Institute in FY27\">Key Risks for Max Healthcare Institute in FY27<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/max-healthcare-institute-analyst-review-2026\/#Conclusion_Max_Healthcare_Institute_Analyst_Review_Verdict_for_2026\" title=\"Conclusion: Max Healthcare Institute Analyst Review Verdict for 2026\">Conclusion: Max Healthcare Institute Analyst Review Verdict for 2026<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/max-healthcare-institute-analyst-review-2026\/#Frequently_Asked_Questions_Max_Healthcare_Institute_Analyst_Review_2026\" title=\"Frequently Asked Questions: Max Healthcare Institute Analyst Review 2026\">Frequently Asked Questions: Max Healthcare Institute Analyst Review 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/max-healthcare-institute-analyst-review-2026\/#What_is_the_analyst_target_for_Max_Healthcare_Institute_in_2026\" title=\"What is the analyst target for Max Healthcare Institute in 2026?\">What is the analyst target for Max Healthcare Institute in 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/max-healthcare-institute-analyst-review-2026\/#Is_Max_Healthcare_Institute_a_good_investment_at_Rs_103720\" title=\"Is Max Healthcare Institute a good investment at Rs 1,037.20?\">Is Max Healthcare Institute a good investment at Rs 1,037.20?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/max-healthcare-institute-analyst-review-2026\/#What_is_Max_Healthcare_Institutes_52-week_high_and_low\" title=\"What is Max Healthcare Institute&#8217;s 52-week high and low?\">What is Max Healthcare Institute&#8217;s 52-week high and low?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/max-healthcare-institute-analyst-review-2026\/#What_are_the_key_risks_for_Max_Healthcare_Institute\" title=\"What are the key risks for Max Healthcare Institute?\">What are the key risks for Max Healthcare Institute?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/max-healthcare-institute-analyst-review-2026\/#Where_can_I_track_live_data_for_Max_Healthcare_Institute\" title=\"Where can I track live data for Max Healthcare Institute?\">Where can I track live data for Max Healthcare Institute?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Max_Healthcare_Institute_Company_Snapshot_May_2026\"><\/span><strong>Max Healthcare Institute Company Snapshot May 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Max Healthcare&#8217;s occupancy at 72 to 75 percent, ARPU expansion through complex procedures (oncology, neurosciences, transplants), and new hospital additions in Delhi NCR and Tier 1 cities drive 20 percent-plus revenue growth. The table below summarises the key data referenced in this <strong>Max Healthcare Institute analyst review<\/strong>.<\/p>\n<table>\n<tbody>\n<tr>\n<th>Parameter<\/th>\n<th>Value<\/th>\n<\/tr>\n<tr>\n<td>NSE Ticker<\/td>\n<td>MAXHEALTH<\/td>\n<\/tr>\n<tr>\n<td>Sector<\/td>\n<td>Healthcare &#8211; Hospitals<\/td>\n<\/tr>\n<tr>\n<td>CMP (May 2026)<\/td>\n<td>Rs 1,037.20<\/td>\n<\/tr>\n<tr>\n<td>52 Week High<\/td>\n<td>Rs 1,314.30<\/td>\n<\/tr>\n<tr>\n<td>52 Week Low<\/td>\n<td>Rs 903.00<\/td>\n<\/tr>\n<tr>\n<td>Market Cap<\/td>\n<td>Rs 1,00,000 Crore<\/td>\n<\/tr>\n<tr>\n<td>Trailing P\/E<\/td>\n<td>90x<\/td>\n<\/tr>\n<tr>\n<td>Analyst Consensus Target<\/td>\n<td>Rs 1,250<\/td>\n<\/tr>\n<tr>\n<td>Bull Case Target<\/td>\n<td>Rs 1,550<\/td>\n<\/tr>\n<tr>\n<td>Bear Case Target<\/td>\n<td>Rs 850<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Analyst_Insight_in_This_Max_Healthcare_Institute_Analyst_Review\"><\/span><strong>Analyst Insight in This Max Healthcare Institute Analyst Review<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Senior Research Analyst <strong>Ankit Jaiswal<\/strong> flags Max Healthcare Institute as a stock to watch in May 2026. At Rs 1,037.20, Ankit Jaiswal identifies key support in the Rs 921 to Rs 985 band and resistance near Rs 1099. He suggests watching Max Healthcare Institute for a potential move toward Rs 1,250, subject to Healthcare &#8211; Hospitals sector momentum and Nifty 50 direction. Ankit Jaiswal&#8217;s view is one input in this <strong>Max Healthcare Institute analyst review<\/strong> and does not constitute a trade recommendation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Technical_Analysis_in_This_Max_Healthcare_Institute_Analyst_Review\"><\/span><strong>Technical Analysis in This Max Healthcare Institute Analyst Review<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>At Rs 1,037.20, MAXHEALTH is trading within its 52-week band of Rs 903.00 to Rs 1,314.30. The current position relative to the 52-week high and low is the first layer of technical context for any entry or exit decision. Momentum indicators including the 14-day RSI, MACD crossover, and volume trends are useful secondary signals to monitor alongside the Nifty 50 direction.<\/p>\n<p>Near-term support is identified in the Rs 921 to Rs 985 band while resistance is seen in the Rs 1099 to Rs 1144 zone. A sustained move above Rs 1099 could open the path toward the analyst consensus target of Rs 1,250.<\/p>\n<p><a href=\"https:\/\/univest.in\/screeners\"><strong>Screen the best stocks on the Univest Screener.<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Support_and_Resistance_Levels\"><\/span><strong>Key Support and Resistance Levels<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Support Zone:<\/strong> Rs 921 to Rs 985 &#8211; investors tracking this <strong>Max Healthcare Institute analyst review<\/strong> should watch for stabilisation or a bounce in this range as a potential accumulation signal for MAXHEALTH.<\/li>\n<li><strong>Resistance Zone:<\/strong> Rs 1099 to Rs 1144 &#8211; a sustained close above Rs 1099 would be a positive breakout signal worth flagging in this <strong>Max Healthcare Institute analyst review<\/strong>.<\/li>\n<li><strong>Medium-Term Target:<\/strong> The analyst consensus of Rs 1,250 represents the base-case upside scenario identified in this <strong>Max Healthcare Institute analyst review<\/strong>.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Business_Segment_Analysis\"><\/span><strong>Business Segment Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Tertiary_and_Quaternary_Care_Hospitals_Delhi_NCR\"><\/span><strong>Tertiary and Quaternary Care Hospitals (Delhi NCR)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>This is the primary revenue and margin driver for Max Healthcare Institute, directly supporting the earnings trajectory toward the consensus target of Rs 1,250.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Oncology_and_Transplant_Centres_of_Excellence\"><\/span><strong>Oncology and Transplant Centres of Excellence<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>This segment adds scale and diversification to Max Healthcare Institute&#8217;s business model and is a meaningful EPS contributor through FY27 and FY28.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"MaxHome_and_Diagnostics_Expanding_Revenue_Streams\"><\/span><strong>Max@Home and Diagnostics (Expanding Revenue Streams)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>This represents the medium-term growth frontier for Max Healthcare Institute and a key re-rating catalyst for the stock over the next 12 to 24 months.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Valuation_in_This_Max_Healthcare_Institute_Analyst_Review\"><\/span><strong>Valuation in This Max Healthcare Institute Analyst Review<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>At Rs 1,037.20, Max Healthcare Institute trades at a trailing P\/E of 90x. This <strong>Max Healthcare Institute analyst review<\/strong> presents three valuation scenarios: a bull case of Rs 1,550 on strong earnings delivery and sector tailwinds, a base case of Rs 1,250 at analyst consensus, and a bear case of Rs 850 if macro headwinds persist. Q1 FY27 results will be the first key checkpoint for this <strong>Max Healthcare Institute analyst review<\/strong>.<\/p>\n<table>\n<tbody>\n<tr>\n<th>Scenario<\/th>\n<th>Target Price<\/th>\n<th>Key Condition<\/th>\n<\/tr>\n<tr>\n<td>Bull Case<\/td>\n<td>Rs 1,550<\/td>\n<td>Strong earnings delivery and sector re-rating<\/td>\n<\/tr>\n<tr>\n<td>Base Case (Consensus)<\/td>\n<td>Rs 1,250<\/td>\n<td>Moderate growth, analyst consensus estimate<\/td>\n<\/tr>\n<tr>\n<td>Bear Case<\/td>\n<td>Rs 850<\/td>\n<td>Earnings miss or macro headwinds<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Trade_Outlook_for_Max_Healthcare_Institute\"><\/span><strong>Trade Outlook for Max Healthcare Institute<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Based on the technical and fundamental analysis in this <strong>Max Healthcare Institute analyst review<\/strong>, investors might watch MAXHEALTH near the support zone of Rs 921 to Rs 985 for potential opportunities. A flag above Rs 1099 could suggest improving momentum toward Rs 1,250. This article uses watch-and-flag language only and does not constitute a trade recommendation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_for_Max_Healthcare_Institute_in_FY27\"><\/span><strong>Key Risks for Max Healthcare Institute in FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>A well-rounded <strong>Max Healthcare Institute analyst review<\/strong> must assess downside risks. Key risks for Max Healthcare Institute include a macro slowdown affecting Healthcare &#8211; Hospitals sector demand, input cost or regulatory headwinds compressing margins, continued FII selling from Indian equities, and earnings estimate downgrades if Q1 FY27 guidance disappoints. Market conditions may change rapidly. This analysis is not financial advice; investors should perform their own due diligence before investing in MAXHEALTH.<\/p>\n<p>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or the <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to get daily stock recommendations and expert research.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion_Max_Healthcare_Institute_Analyst_Review_Verdict_for_2026\"><\/span><strong>Conclusion: Max Healthcare Institute Analyst Review Verdict for 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>This <strong>Max Healthcare Institute analyst review<\/strong> concludes that at Rs 1,037.20, MAXHEALTH offers a defined risk-reward with a consensus target of Rs 1,250. The 52-week range of Rs 903.00 to Rs 1,314.30 provides context on the current entry point. Use this <strong>Max Healthcare Institute analyst review<\/strong> as a research starting point and consult a SEBI-registered financial advisor before making any investment decisions on MAXHEALTH.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_Max_Healthcare_Institute_Analyst_Review_2026\"><\/span><strong>Frequently Asked Questions: Max Healthcare Institute Analyst Review 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_analyst_target_for_Max_Healthcare_Institute_in_2026\"><\/span><strong>What is the analyst target for Max Healthcare Institute in 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The analyst consensus target is Rs 1,250, with a bull case of Rs 1,550 and a bear case of Rs 850. Monitor Q1 FY27 earnings for confirmation as highlighted in this <strong>Max Healthcare Institute analyst review<\/strong>.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Max_Healthcare_Institute_a_good_investment_at_Rs_103720\"><\/span><strong>Is Max Healthcare Institute a good investment at Rs 1,037.20?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>At Rs 1,037.20 with a P\/E of 90x and a consensus target of Rs 1,250, this <strong>Max Healthcare Institute analyst review<\/strong> is constructive for medium to long-term investors in the Healthcare &#8211; Hospitals sector. Always consult a SEBI-registered advisor before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Max_Healthcare_Institutes_52-week_high_and_low\"><\/span><strong>What is Max Healthcare Institute&#8217;s 52-week high and low?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The 52-week high is Rs 1,314.30 and the 52-week low is Rs 903.00. At Rs 1,037.20, MAXHEALTH is positioned within this range as noted in this <strong>Max Healthcare Institute analyst review<\/strong>.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_risks_for_Max_Healthcare_Institute\"><\/span><strong>What are the key risks for Max Healthcare Institute?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Key risks include macro slowdown, input cost pressures, FII selling, and regulatory changes in the Healthcare &#8211; Hospitals sector as assessed in this <strong>Max Healthcare Institute analyst review<\/strong>.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Where_can_I_track_live_data_for_Max_Healthcare_Institute\"><\/span><strong>Where can I track live data for Max Healthcare Institute?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Track Max Healthcare Institute&#8217;s live price and analyst targets on the Univest Screener alongside professional financial advice to complement this <strong>Max Healthcare Institute analyst review<\/strong>.<\/p>\n<p><em>Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice. Please consult a SEBI-registered financial advisor before making any investment decisions.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Max Healthcare Institute analyst review 2026: CMP Rs 1,037.20, MCap Rs 1,00,000 Cr, PE 90x. Healthcare &#8211; Hospitals outlook and technical levels. May 2026.<\/p>\n","protected":false},"author":28,"featured_media":90811,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802],"class_list":["post-90516","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1779101974:28"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["82"],"rank_math_title":["Max Healthcare Institute Analyst Review 2026"],"rank_math_description":["Max Healthcare Institute analyst review 2026: CMP Rs 1,037.20, MCap Rs 1,00,000 Cr, PE 90x. Healthcare - Hospitals outlook and technical levels. May 2026."],"rank_math_focus_keyword":["Max Healthcare Institute Analyst Review"],"rank_math_robots":["a:2:{i:0;s:8:\"nofollow\";i:1;s:7:\"noindex\";}"],"_thumbnail_id":["90811"],"_edit_last":["28"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["12095"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/05\/18162854\/Max-Healthcare-Institute-Analyst-Review.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/90516","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/28"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=90516"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/90516\/revisions"}],"predecessor-version":[{"id":90812,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/90516\/revisions\/90812"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/90811"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=90516"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=90516"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=90516"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}